Wells Fargo & Company Biotricity Inc. Transaction History

Wells Fargo & Company

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$0.46 - $0.79 $5 - $10	13 Added 4.81%	283 $0
Q1 2023 May 12, 2023	BUY	$0.44 - $0.88 $2 - $5	6 Added 2.27%	270 $0
Q4 2022 Feb 13, 2023	BUY	$0.45 - $1.29 $3 - $9	7 Added 2.72%	264 $0
Q3 2022 Nov 14, 2022	SELL	$0.78 - $1.75 $21 - $47	-27 Reduced 9.51%	257 $0
Q2 2022 Aug 12, 2022	BUY	$0.96 - $2.36 $22 - $54	23 Added 8.81%	284 $1,000
Q1 2022 May 16, 2022	BUY	$2.27 - $4.03 $27 - $48	12 Added 4.82%	261 $1,000
Q4 2021 Feb 14, 2022	BUY	$2.7 - $4.67 $672 - $1,162	249 New	249 $1,000

834

Ticker BTCY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 50,431,200
Market Cap $14.1M
Description
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile ...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.